Articles

Article - Comment

Can effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy?

Sadik Görür
Murat Bozlu

Bull Urooncol 2006; 5: 26-27

Under diagnosis and over diagnosis of prostate cancer

Mustafa Kaplan

Bull Urooncol 2007; 6: 29-33

Saturation Technique Does Not Decrease Cancer Detection During Followup After Initial Prostate Biopsy

Ali İhsan Arık

Bull Urooncol 2008; 7: 38-40

Original Article

What is the Prostate-Specific Antigen Cut-Off Value to Detect Clinically Significant Prostate Cancer According to Age in Turkey?

Turgay Ebiloğlu
Engin Kaya

Bull Urooncol 2018; 17: 49-53 DOI: 10.4274/uob.970

Assessment of the Relationship Between Serum Prostate-Specific Antigen Level and Serum Fasting Glucose, Total Cholesterol and Neutrophil-Lymphocyte Ratio in Men Aged 50-70 Years with Prostate-Specific Antigen Level 0-10 ng/mL without Prostate Cancer Diagnosis

Bora İrer

Bull Urooncol 2018; 17: 59-62 DOI: 10.4274/uob.999

Socioeconomic Predictors and Patient Perspectives of Prostate-specific Antigen Testing

Bora İrer

Bull Urooncol 2018; 17: 94-97 DOI: 10.4274/uob.1086

Original Articles

Evaluation of the Relationship between Pathology Results and Pain Scores in Patients Who Underwent Transrectal Ultrasound-Guided Prostate

Deniz Bolat
Mehmet Erhan Aydın
Bülent Günlüsoy
Tansu Değirmenci
Yusuf Kadir Topçu
İbrahim Küçüktürkmen
Yasin Ceylan
Ertuğrul Şefik

Bull Urooncol 2016; 15: 86-89 DOI: 10.4274/uob.666

Review

Active Surveillance in Prostate Cancer: Can We Expand the Indications?

Hacı Murat Akgül
Asgar Garayev
İlker Tinay

Bull Urooncol 2016; 15: 163-166 DOI: 10.4274/uob.619

Bph

The current status of prostate-specific antigen in the management of Benign Prostatic Hyperplasia

Ali Tekin

Bull Urooncol 2013; 12: 232-236

1
2

About Journal

Forms

Useful Links

Latest Update: 04.04.2024